#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	18080	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2075	865.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1716	1716	T	1045	T,C,G	944,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	18080	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2075	865.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1450	1450	C	1031	C	958	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33156	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3591	921.0	0	.	n	.	0	T695C	SNP	695	695	T	1060	1060	C	987	C	914	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33156	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3591	921.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	2003	2003	G	1109	G,A	1046,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33156	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3591	921.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2336	2336	C	1078	C,T	1001,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33156	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3591	921.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2410	2410	A	1064	A	996	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33156	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3591	921.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2962	2962	C	1079	C	1006	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	2372	folP	852	852	100.0	folP.l15.c30.ctg.1	1635	144.5	1	SNP	p	R228S	0	.	.	682	684	CGC	1083	1085	CGC	240;238;239	C,A;G,A;C	226,1;222,1;221	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5684	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3507	161.7	1	SNP	p	S91F	0	.	.	271	273	TCC	618	620	TCC	208;209;211	T;C;C	197;195;198	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5684	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3507	161.7	1	SNP	p	D95G	0	.	.	283	285	GAC	630	632	GAC	212;208;207	G;A,G;C	202;197,1;196	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5684	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3507	161.7	1	SNP	p	D95N	0	.	.	283	285	GAC	630	632	GAC	212;208;207	G;A,G;C	202;197,1;196	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1944	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1175	164.2	1	SNP	p	G45D	1	.	.	133	135	GAC	394	396	GAC	247;247;251	G;A;C	229;227;233	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	930	mtrR_promoter	250	250	99.2	mtrR_promoter.l6.c30.ctg.1	1125	82.5	0	.	n	.	0	T10C	SNP	10	10	T	518	518	C	185	C	177	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	930	mtrR_promoter	250	250	99.2	mtrR_promoter.l6.c30.ctg.1	1125	82.5	0	.	n	.	0	A197.	DEL	197	197	A	704	704	A	246	A	226	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5254	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3010	174.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1611	1613	GCA	224;220;221	G,A;C,T;A,G	201,1;192,1;189,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5254	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3010	174.2	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2094	2096	ATT	200;203;203	A,C,G;T;T,C	184,1,1;190;191,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5254	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3010	174.2	1	SNP	p	D86N	0	.	.	256	258	GAC	564	566	GAC	220;221;219	G;A;C	209;210;207	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5254	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3010	174.2	1	SNP	p	S87R	0	.	.	259	261	AGT	567	569	AGT	219;218;219	A;G;T	208;207;207	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5254	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3010	174.2	1	SNP	p	S87I	0	.	.	259	261	AGT	567	569	AGT	219;218;219	A;G;T	208;207;207	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5254	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3010	174.2	1	SNP	p	S87W	0	.	.	259	261	AGT	567	569	AGT	219;218;219	A;G;T	208;207;207	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5254	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3010	174.2	1	SNP	p	S88P	0	.	.	262	264	TCC	570	572	TCC	217;220;220	T;C;C	205;205;208	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4912	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2793	175.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1613	1615	GGC	264;261;266	G,T;G;C	242,1;234;240	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	5886	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2564	228.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1332	1334	GCA	298;305;306	G,A;C,T;A	277,1;280,1;284	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5886	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2564	228.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1335	1337	ATC	309;308;308	A;T;C	291;289;285	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5886	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2564	228.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1347	1349	GTG	323;321;322	G;T;G	299;294;297	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5886	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2564	228.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1347	1349	GTG	323;321;322	G;T;G	299;294;297	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5886	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2564	228.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1851	1853	ACC	314;314;316	A;C;C	284;292;291	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5886	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2564	228.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1905	1907	GCG	305;301;298	G;C,A,G;G	272;242,1,1;252	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5886	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2564	228.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1905	1907	GCG	305;301;298	G;C,A,G;G	272;242,1,1;252	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5886	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2564	228.8	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2028	2030	GGT	274;273;270	G;G;T	255;255;253	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5886	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2564	228.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2037	2039	GGC	269;266;268	G;G;C	250;246;247	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	5886	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2564	228.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2055	2057	CCG	258;260;259	C;C;G	190;218;203	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6722	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3138	213.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1589	1591	CCG	219;218;216	C;C;G	193;199;187	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2350	porA	1146	1146	99.65	porA.l15.c30.ctg.1	1939	120.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	417	419	GGC	176;174;177	G,A;G;C,A	161,1;157;162,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2350	porA	1146	1146	99.65	porA.l15.c30.ctg.1	1939	120.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	599	599	C	173	C	159	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3800	porB1b	1047	1047	99.81	porB1b.l15.c17.ctg.1	1518	249.3	0	.	p	.	0	G120D	NONSYN	358	360	GGC	685	687	GAC	285;286;287	G;A;C	269;270;269	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3800	porB1b	1047	1047	99.81	porB1b.l15.c17.ctg.1	1518	249.3	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	688	690	AAC	285;284;285	A;A;C	269;267;268	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	14604	rpoB	4179	4179	100.0	rpoB.l6.c17.ctg.1	4767	305.5	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1981	1983	CAT	318;321;324	C;A;T	300;304;305	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1560	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	917	167.2	1	SNP	p	V57M	0	.	.	169	171	GTG	471	473	GTG	312;312;313	G;T;G	294;291;294	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
